New Hope For Esophageal Cancer Patients — Immunotherapy Opdivo Approved For Treatment Of Advanced Esophageal Cancer

Updated February 2nd, 2022

New Hope For Esophageal Cancer Patients — Immunotherapy Opdivo Approved For Treatment Of Advanced Esophageal Cancer

Checkpoint inhibitor OPDIVO has shown tremendous promise for patients battling advanced esophageal cancer. An expert tells SurvivorNet that in esophageal cancer, anything that improves survival in patients whose disease already progresses after chemotherapy is remarkable.

NOW
PLAYING
'JoJo's Bizarre Adventure' Star Billy Kametz, 35, Announces Stage 4 Colon Cancer, Will 'Take Time Off' Show
NOW
PLAYING
Understanding PI3K Inhibitors: How Can This Type of Targeted Therapy Treat CLL?
NOW
PLAYING
How Does Atezolizumab (Tecentriq) Treat Lung Cancer?
NOW
PLAYING
How is Melanoma Treated After Surgery?
NOW
PLAYING
April Is Testicular Cancer Awareness Month – Here's What You Should Know
NOW
PLAYING
The Importance of Genetic Testing After a CLL Diagnosis

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.